Get Premium to unlock powerful stock data

Oracle Investment Management Inc Buys Vir Biotechnology Inc, Atea Pharmaceuticals Inc, Guardant Health Inc, Sells SPDR Biotech ETF, Capricor Therapeutics Inc, Motus GI Holdings Inc

Author's Avatar
insider
Nov 17, 2021
Article's Main Image
Greenwich, CT, based Investment company Oracle Investment Management Inc (Current Portfolio) buys Vir Biotechnology Inc, Atea Pharmaceuticals Inc, Guardant Health Inc, Forian Inc, Madrigal Pharmaceuticals Inc, sells SPDR Biotech ETF, Capricor Therapeutics Inc, Motus GI Holdings Inc, Biodesix Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Oracle Investment Management Inc. As of 2021Q3, Oracle Investment Management Inc owns 40 stocks with a total value of $803 million. These are the details of the buys and sells.

For the details of ORACLE INVESTMENT MANAGEMENT INC's stock buys and sells, go to https://www.gurufocus.com/guru/oracle+investment+management+inc/current-portfolio/portfolio

These are the top 5 holdings of ORACLE INVESTMENT MANAGEMENT INC
  1. Biohaven Pharmaceutical Holding Co Ltd (BHVN) - 2,124,055 shares, 36.73% of the total portfolio. Shares added by 1.99%
  2. Quidel Corp (QDEL) - 906,655 shares, 15.93% of the total portfolio. Shares added by 8.31%
  3. Vir Biotechnology Inc (VIR) - 1,181,357 shares, 6.40% of the total portfolio. Shares added by 67.45%
  4. Agenus Inc (AGEN) - 9,437,334 shares, 6.17% of the total portfolio. Shares added by 2.88%
  5. OPKO Health Inc (OPK) - 12,819,073 shares, 5.83% of the total portfolio.
New Purchase: Atea Pharmaceuticals Inc (AVIR)

Oracle Investment Management Inc initiated holding in Atea Pharmaceuticals Inc. The purchase prices were between $21.33 and $35.06, with an estimated average price of $27.69. The stock is now traded at around $11.360000. The impact to a portfolio due to this purchase was 1.35%. The holding were 309,126 shares as of 2021-09-30.

New Purchase: Guardant Health Inc (GH)

Oracle Investment Management Inc initiated holding in Guardant Health Inc. The purchase prices were between $98.77 and $132.17, with an estimated average price of $119.09. The stock is now traded at around $105.230000. The impact to a portfolio due to this purchase was 1.09%. The holding were 70,000 shares as of 2021-09-30.

New Purchase: Madrigal Pharmaceuticals Inc (MDGL)

Oracle Investment Management Inc initiated holding in Madrigal Pharmaceuticals Inc. The purchase prices were between $78.35 and $105.02, with an estimated average price of $86.48. The stock is now traded at around $89.540000. The impact to a portfolio due to this purchase was 0.38%. The holding were 38,500 shares as of 2021-09-30.

New Purchase: Protagenic Therapeutics Inc (PTIX)

Oracle Investment Management Inc initiated holding in Protagenic Therapeutics Inc. The purchase prices were between $1.75 and $2.77, with an estimated average price of $2.15. The stock is now traded at around $1.940000. The impact to a portfolio due to this purchase was 0.12%. The holding were 500,000 shares as of 2021-09-30.

New Purchase: XBiotech Inc (XBIT)

Oracle Investment Management Inc initiated holding in XBiotech Inc. The purchase prices were between $12.95 and $18.24, with an estimated average price of $15.94. The stock is now traded at around $14.040000. The impact to a portfolio due to this purchase was 0.03%. The holding were 350,000 shares as of 2021-09-30.

Added: Vir Biotechnology Inc (VIR)

Oracle Investment Management Inc added to a holding in Vir Biotechnology Inc by 67.45%. The purchase prices were between $34.9 and $54.54, with an estimated average price of $43.35. The stock is now traded at around $33.420000. The impact to a portfolio due to this purchase was 2.58%. The holding were 1,181,357 shares as of 2021-09-30.

Added: Forian Inc (FORA)

Oracle Investment Management Inc added to a holding in Forian Inc by 38.19%. The purchase prices were between $9.89 and $12.73, with an estimated average price of $11.12. The stock is now traded at around $10.230000. The impact to a portfolio due to this purchase was 0.43%. The holding were 1,199,960 shares as of 2021-09-30.

Added: Select Medical Holdings Corp (SEM)

Oracle Investment Management Inc added to a holding in Select Medical Holdings Corp by 68.96%. The purchase prices were between $32.28 and $42.64, with an estimated average price of $36.91. The stock is now traded at around $33.070000. The impact to a portfolio due to this purchase was 0.27%. The holding were 149,678 shares as of 2021-09-30.

Sold Out: SPDR Biotech ETF (XBI)

Oracle Investment Management Inc sold out a holding in SPDR Biotech ETF. The sale prices were between $118.69 and $138.49, with an estimated average price of $128.78.

Sold Out: Capricor Therapeutics Inc (CAPR)

Oracle Investment Management Inc sold out a holding in Capricor Therapeutics Inc. The sale prices were between $3.8 and $5.23, with an estimated average price of $4.57.



Here is the complete portfolio of ORACLE INVESTMENT MANAGEMENT INC. Also check out:

1. ORACLE INVESTMENT MANAGEMENT INC's Undervalued Stocks
2. ORACLE INVESTMENT MANAGEMENT INC's Top Growth Companies, and
3. ORACLE INVESTMENT MANAGEMENT INC's High Yield stocks
4. Stocks that ORACLE INVESTMENT MANAGEMENT INC keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus